Introduction of 163847-77-6 :
TAPI-1 is a TACE (ADAM17) inhibitor and blocks the shedding of several cell surface proteins[1]. TAPI-1 is also a metalloproteinase (MMP) inhibitor[2]. IC50 & Target: TACE (ADAM17)[1], MMP[2] In Vitro: TAPI-1 (1 µM for 30 min) increases cell viability in LPS-treated HK-2 cells[1].
TAPI-1 attenuates oxidative stress and inflammatory cytokines[1]
LPS treatment significantly induces renal IL-6 and TNFα mRNA expression, while these changes is attenuated with TAPI-1 pretreatment in LPS-treated HK-2 cells[1].